These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2247 related items for PubMed ID: 26560028

  • 1. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
    Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R.
    Nature; 2015 Nov 26; 527(7579):525-530. PubMed ID: 26560028
    [Abstract] [Full Text] [Related]

  • 2. Glial cell-derived soluble factors increase the metastatic potential of pancreatic adenocarcinoma cells and induce epithelial-to-mesenchymal transition.
    García-Reyes B, Kuzmanov I, Schneider R, Schneiker B, Efferz P, Kalff JC, Wehner S.
    J Cancer Res Clin Oncol; 2023 Nov 26; 149(15):14315-14327. PubMed ID: 37572121
    [Abstract] [Full Text] [Related]

  • 3. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer.
    Carstens JL, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews KM, Rao A, Burks JK, Rhim AD, Kalluri R.
    Cell Rep; 2021 Apr 13; 35(2):108990. PubMed ID: 33852841
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J, Yang R, Dong Y, Chen M, Wang Y, Wang G.
    J Exp Clin Cancer Res; 2019 Jan 28; 38(1):38. PubMed ID: 30691517
    [Abstract] [Full Text] [Related]

  • 5. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
    Nishino H, Takano S, Yoshitomi H, Suzuki K, Kagawa S, Shimazaki R, Shimizu H, Furukawa K, Miyazaki M, Ohtsuka M.
    Cancer Med; 2017 Nov 28; 6(11):2686-2696. PubMed ID: 28960866
    [Abstract] [Full Text] [Related]

  • 6. Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma.
    Sugimoto T, Iwagami Y, Kobayashi S, Yamanaka C, Sasaki K, Yamada D, Tomimaru Y, Asaoka T, Noda T, Takahashi H, Shimizu J, Doki Y, Eguchi H.
    Ann Surg Oncol; 2024 Jun 28; 31(6):3718-3736. PubMed ID: 38502294
    [Abstract] [Full Text] [Related]

  • 7. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.
    Okada Y, Takahashi N, Takayama T, Goel A.
    Carcinogenesis; 2021 Apr 30; 42(4):546-556. PubMed ID: 33624791
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
    Chen S, Chen JZ, Zhang JQ, Chen HX, Yan ML, Huang L, Tian YF, Chen YL, Wang YD.
    Cancer Lett; 2016 Dec 01; 383(1):73-84. PubMed ID: 27693633
    [Abstract] [Full Text] [Related]

  • 9. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G, Ji L, Ke M, Ou Z, Tang N, Li Y.
    Biomed Pharmacother; 2018 Oct 01; 106():523-531. PubMed ID: 29990840
    [Abstract] [Full Text] [Related]

  • 10. Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
    Meng Q, Shi S, Liang C, Liang D, Hua J, Zhang B, Xu J, Yu X.
    Oncogene; 2018 Nov 01; 37(44):5843-5857. PubMed ID: 29980787
    [Abstract] [Full Text] [Related]

  • 11. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Li K, Xu B, Xu G, Liu R.
    Tumour Biol; 2016 Jan 01; 37(1):419-24. PubMed ID: 26219899
    [Abstract] [Full Text] [Related]

  • 12. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK, Leon F, Rachagani S, Rauth S, Nallasamy P, Marimuthu S, Shailendra GK, Chhonker YS, Chugh S, Chirravuri R, Gupta R, Mallya K, Prajapati DR, Lele SM, C Caffrey T, L Grem J, Grandgenett PM, Hollingsworth MA, Murry DJ, Batra SK, Ponnusamy MP.
    Oncogene; 2021 Jan 01; 40(1):215-231. PubMed ID: 33110235
    [Abstract] [Full Text] [Related]

  • 13. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.
    Li A, Morton JP, Ma Y, Karim SA, Zhou Y, Faller WJ, Woodham EF, Morris HT, Stevenson RP, Juin A, Jamieson NB, MacKay CJ, Carter CR, Leung HY, Yamashiro S, Blyth K, Sansom OJ, Machesky LM.
    Gastroenterology; 2014 May 01; 146(5):1386-96.e1-17. PubMed ID: 24462734
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ, Fu ZG, Meng Y, Wu XQ, Wu B, Xu L, Jiang JL, Li L, Chen ZN.
    Oncotarget; 2016 Sep 20; 7(38):62177-62193. PubMed ID: 27556697
    [Abstract] [Full Text] [Related]

  • 15. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, Yu X.
    Pancreatology; 2021 Apr 20; 21(3):589-598. PubMed ID: 33579599
    [Abstract] [Full Text] [Related]

  • 16. Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance.
    Gordon ER, Wright CA, James M, Cooper SJ.
    BMC Cancer; 2023 Jun 08; 23(1):524. PubMed ID: 37291514
    [Abstract] [Full Text] [Related]

  • 17. Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma.
    Satoh K, Hamada S, Shimosegawa T.
    J Gastroenterol; 2015 Feb 08; 50(2):140-6. PubMed ID: 25216997
    [Abstract] [Full Text] [Related]

  • 18. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.
    Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, Zheng S, Zhuang B, Chen H, Li W, Li H, Li H, Fu Z, Chen R.
    J Transl Med; 2015 Mar 12; 13():84. PubMed ID: 25889214
    [Abstract] [Full Text] [Related]

  • 19. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS, Chung I, Wong WF, Masamune A, Sim MS, Looi CY.
    Biochim Biophys Acta Gen Subj; 2017 Feb 12; 1861(2):296-306. PubMed ID: 27750041
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M, Alishahi Z, Eyvani H, Esmaeili F, Zaghal A, Ghaffari P, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.
    Cell Oncol (Dordr); 2020 Feb 12; 43(1):81-93. PubMed ID: 31512195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 113.